1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
- 2022
-
Mark
Short‐Term Blockade of Pro‐Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post‐Myocardial Infarction Recovery
(
- Contribution to journal › Article
- 2021
-
Mark
Studying the innate immune response to myocardial infarction in a highly efficient experimental animal model
(
- Contribution to journal › Article
- 2019
-
Mark
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction
(
- Contribution to journal › Article
- 2018
-
Mark
Innate immune mechanisms in myocardial infarction - An update
(
- Contribution to journal › Scientific review